As of June 17, 2022, Grove Collaborative, Inc., a certified B Corp™ and leading sustainable consumer products company, and Virgin Group Acquisition Corp. II (“VGII”) (NYSE: VGII), a publicly traded special purpose acquisition company sponsored by Virgin Group, completed their previously announced business combination.
The transaction was approved on June 14, 2022 by VGII’s shareholders. In connection with consummation of the business combination, VGII changed its name to “Grove Collaborative Holdings, Inc.” (“New Grove”). New Grove’s shares and warrants began trading on the New York Stock Exchange (”NYSE”) under the ticker symbols “GROV” and “GROV WS”, respectively on June 17, 2022.
As of June 16, 2021, 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, completed their previously announced business combination. The transaction, which was approved on June 10, 2021 by VG Acquisition Corp.’s shareholders, uniquely positions 23andMe to revolutionize personalized healthcare and therapeutic development through human genetics. The combined company is called 23andMe Holding Co. and will be traded on The Nasdaq Global Select Market (“Nasdaq”) beginning on June 17, 2021 under the new ticker symbol “ME”